It was demonstrated that in leiomyomas, CpG sites were hypomethylated in the distal region of the estrogen receptor-alpha (ER-alpha) promoter combined with the higher ER-alpha mRNA levels (Asada et al., 2008). The gene discussed is ESR1; the disease is leiomyoma.